1.
Mulder MB, Birnie E, Dijck – van Boetzelaer C van, van de Geijn G-J, Boevé E, Westerman EM, et al. Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial). AO [Internet]. 2021 Apr. 3 [cited 2026 May 31];60(4):539-43. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/21482